{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:43:38Z","timestamp":1783035818412,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00115-025-01933-4","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:37:29Z","timestamp":1766057849000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["All about nothing? Wie steht es um das Risiko kindlicher Entwicklungsst\u00f6rungen bei v\u00e4terlicher Valproins\u00e4ure-Behandlung?","All about nothing? What about the risk for developmental disorders in offsprings after paternal exposure with valproic acid?"],"prefix":"10.1007","volume":"97","author":[{"given":"Michael","family":"Paulzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivia","family":"Ochmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"1933_CR1","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1007\/s00415-024-12436-8","volume":"271","author":"H Angus-Leppan","year":"2024","unstructured":"Angus-Leppan\u00a0H, Arkell\u00a0R, Watkins\u00a0L, Heaney\u00a0D, Cooper\u00a0P, Shankar\u00a0R (2024) New valproate regulations, informed choice and seizure risk. J\u00a0Neurol 271:5671\u20135686","journal-title":"J Neurol"},{"key":"1933_CR2","doi-asserted-by":"publisher","first-page":"107562","DOI":"10.1016\/j.yebeh.2020.107562","volume":"114","author":"M Casale","year":"2021","unstructured":"Casale\u00a0M, Lemus\u00a0HN, Young\u00a0JJ, Marcuse\u00a0LV, Yoo\u00a0JY, Faktorovich\u00a0S, Mueller\u00a0B, Fields\u00a0MC (2021) Psychiatric comorbidities, sexual health and neurodevelopmental outcomes of offspring in men with epilepsy. Epilepsy Behav 114:107562","journal-title":"Epilepsy Behav"},{"key":"1933_CR3","doi-asserted-by":"publisher","first-page":"e2512139","DOI":"10.1001\/jamanetworkopen.2025.12139","volume":"8","author":"J Christensen","year":"2025","unstructured":"Christensen\u00a0J, Trabjerg\u00a0BB, Dreier\u00a0JW (2025) Risk of Neurodevelopmental Disorders and Paternal Use of Valproate During Spermatogenesis. Jama Netw Open 8:e2512139","journal-title":"Jama Netw Open"},{"key":"1933_CR4","doi-asserted-by":"publisher","first-page":"e2414709","DOI":"10.1001\/jamanetworkopen.2024.14709","volume":"7","author":"J Christensen","year":"2024","unstructured":"Christensen\u00a0J, Trabjerg\u00a0BB, Dreier\u00a0JW (2024) Valproate Use During Spermatogenesis and Risk to Offspring. Jama Netw Open 7:e2414709\u2013e2414709","journal-title":"Jama Netw Open"},{"key":"1933_CR5","doi-asserted-by":"publisher","first-page":"e2542581","DOI":"10.1001\/jamanetworkopen.2025.42581","volume":"8","author":"S Colas","year":"2025","unstructured":"Colas\u00a0S, Longin\u00a0J, Santos\u00a0AC, Kaplan\u00a0S, Di Giuseppe\u00a0R, Bigat\u00a0D, Venerus\u00a0A, Bj\u00f8rk\u00a0MH, K\u00fcrzinger\u00a0ML, Cilio\u00a0MR, Richy\u00a0F (2025) Paternal Valproate Use and Neurodevelopmental Disorder and Congenital Malformation Risk in Offspring. Jama Netw Open 8:e2542581","journal-title":"Jama Netw Open"},{"key":"1933_CR6","unstructured":"European Medicines Agency (EMA) (2024) Precautionary measures to address potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines. https:\/\/www.ema.europa.eu\/en\/news\/precautionary-measures-address-potential-risk-neurodevelopmental-disorders-children-born-men-treated-valproate-medicines#related-content-65245. Zugegriffen: 1. Dez. 2025"},{"key":"1933_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jnnp-2024-334077","volume":"96","author":"E Honybun","year":"2025","unstructured":"Honybun\u00a0E, Rayner\u00a0G, Malpas\u00a0CB, O\u2019brien\u00a0TJ, Vajda\u00a0FJ, Perucca\u00a0P, Perucca\u00a0E (2025) Paternal exposure to antiseizure medications and offspring outcomes: a\u00a0systematic review. J\u00a0Neurol Neurosurg & Psychiatry 96:15\u201325","journal-title":"J Neurol Neurosurg & Psychiatry"},{"key":"1933_CR8","unstructured":"IQVIA (2020) A post-authorization safety study (PASS) to evaluate the paternal exposure to valproate and the risk of neurodevelopmental disorders including autism spectrum disorders as well as congenital abnormalities in offspring\u2014a population-based retrospective study. https:\/\/catalogues.ema.europa.eu\/node\/3611\/administrative-details. Zugegriffen: 1. Dez. 2025 ((EUPASS34201))"},{"key":"1933_CR9","first-page":"37","volume":"2","author":"F Majewski","year":"1981","unstructured":"Majewski\u00a0F, Steger\u00a0M, Richter\u00a0B, Gill\u00a0J, Rabe\u00a0F (1981) The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy 2:37\u201345","journal-title":"Int J Biol Res Pregnancy"},{"key":"1933_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/ane.13311","volume":"142","author":"S Markoula","year":"2020","unstructured":"Markoula\u00a0S, Siarava\u00a0E, Kostoulas\u00a0C, Zikopoulos\u00a0A, Georgiou\u00a0I (2020) An open study of valproate in subfertile men with epilepsy. Acta Neurol Scand 142:317\u2013322","journal-title":"Acta Neurol Scand"},{"key":"1933_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000114274","volume":"10","author":"JG Meyer","year":"1973","unstructured":"Meyer\u00a0JG (1973) The teratological effects of anticonvulsants and the effects on pregnancy and birth. Eur Neurol 10:179\u2013190","journal-title":"Eur Neurol"},{"key":"1933_CR12","first-page":"1","volume-title":"Paternal exposure to antiseizure medications and offspring outcomes: a\u00a0systematic review and meta-analysis of observational studies","author":"V Ochmann","year":"2025","unstructured":"Ochmann\u00a0V, Gkoltsos\u00a0C, Gastaldon\u00a0C, Barbui\u00a0C, Seifritz\u00a0E, Spigset\u00a0O, Tomson\u00a0T, Schoretsanitis\u00a0G (2025) Paternal exposure to antiseizure medications and offspring outcomes: a\u00a0systematic review and meta-analysis of observational studies. Expert, Opin Drug Metab Toxicol, S\u00a01\u20138"},{"key":"1933_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s00115-023-01528-x","volume":"94","author":"M Paulzen","year":"2023","unstructured":"Paulzen\u00a0M, Schoretsanitis\u00a0G (2023) Psychopharmacotherapy during pregnancy and breastfeeding-Part\u00a0I:\u00a0focus on pregnancy : Support options by using therapeutic drug monitoring. Nervenarzt 94:786\u2013798","journal-title":"Nervenarzt"},{"key":"1933_CR14","doi-asserted-by":"crossref","unstructured":"Practice Guideline from the Practice Guideline From the AAN, AES, and SMFM, Pack AM, Oskoui M, Roberson SW, Donley DK, French J, Gerard EE, Gloss D, Miller WR, Clary HMM, Osmundson SS, Mcfadden B, Parratt K, Pennell PB, Saade G, Smith DB, Sullivan K, Thomas SV, Tomson T, O\u2019brien MD, Botchway-Doe K, Silsbee HM, Keezer MR (2025) Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication. Epilepsy Curr:15357597241258514","DOI":"10.1212\/WNL.0000000000209279"},{"key":"1933_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","volume":"2","author":"E Robert","year":"1982","unstructured":"Robert\u00a0E, Guibaud\u00a0P (1982) Maternal valproic acid and congenital neural tube defects. Lancet 2:937","journal-title":"Lancet"},{"key":"1933_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/jnnp-2020-323028","volume":"91","author":"T Tomson","year":"2020","unstructured":"Tomson\u00a0T, Muraca\u00a0G, Razaz\u00a0N (2020) Paternal exposure to antiepileptic drugs and offspring outcomes: a\u00a0nationwide population-based cohort study in Sweden. J\u00a0Neurol Neurosurg Psychiatry 91:907\u2013913","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1933_CR17","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/epi.12226","volume":"54","author":"G Veiby","year":"2013","unstructured":"Veiby\u00a0G, Daltveit\u00a0AK, Schjolberg\u00a0S, Stoltenberg\u00a0C, Oyen\u00a0AS, Vollset\u00a0SE, Engelsen\u00a0BA, Gilhus\u00a0NE (2013) Exposure to antiepileptic drugs in utero and child development: a\u00a0prospective population-based study. Epilepsia 54:1462\u20131472","journal-title":"Epilepsia"},{"key":"1933_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","volume":"15","author":"AA Veroniki","year":"2017","unstructured":"Veroniki\u00a0AA, Cogo\u00a0E, Rios\u00a0P, Straus\u00a0SE, Finkelstein\u00a0Y, Kealey\u00a0R, Reynen\u00a0E, Soobiah\u00a0C, Thavorn\u00a0K, Hutton\u00a0B, Hemmelgarn\u00a0BR, Yazdi\u00a0F, D\u2019souza\u00a0J, Macdonald\u00a0H, Tricco\u00a0AC (2017) Comparative safety of anti-epileptic drugs during pregnancy: a\u00a0systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 15:95","journal-title":"BMC Med"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-025-01933-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-025-01933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:45:47Z","timestamp":1768477547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-025-01933-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1007\/s00115-025-01933-4","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Paulzen, V.\u00a0Ochmann und G.\u00a0Schoretsanitis geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}